Fossa Anthony A, Wisialowski Todd, Crimin Kimberly, Wolfgang Eric, Couderc Jean-Philippe, Hinterseer Martin, Kaab Stefan, Zareba Wojciech, Badilini Fabio, Sarapa Nenad
Pfizer Global Research and Development, Groton, Connecticut 06340, USA.
Ann Noninvasive Electrocardiol. 2007 Oct;12(4):338-48. doi: 10.1111/j.1542-474X.2007.00183.x.
Restitution through intracardiac pacing has been used to assess arrhythmia vulnerability. We examined whether analyses of sequential beat-to-beat QT and TQ interval measures can be used to quantify ECG restitution changes under normal sinus rhythm.
The QT, R-R and TQ intervals were examined 22.5 hour Holter monitoring before and after oral sotalol in normal male and female volunteers. Additionally, comparisons were made to those observed in the time-matched dataset prior to torsades de pointes in a heart diseased patient that received a single dose of sotalol.
Sotalol increased QT, R-R and TQ intervals 71, 101, and 125 ms after 160 mg (n = 38) and 194, 235, and 135 ms after 320 mg (n = 19) during maximum plasma concentrations, respectively. The percentage of beats with a QT/TQ ratio >1 was reduced 25% over the entire 22.5 hours after sotalol and the lower TQ interval boundary (5th quantile) was increased 22-30%. In contrast, 99% of the beats prior to torsades de pointes had a QT/TQ ratio > 1 and the median TQ interval was below the lower 98% confidence bounds of normals before and after sotalol.
ECG restitution changes are quantifiable under varying states (nocturnally, beta-adrenergic blockade, QT prolongation) in healthy subjects.
通过心内起搏进行恢复已被用于评估心律失常易感性。我们研究了逐搏QT和TQ间期测量分析是否可用于量化正常窦性心律下的心电图恢复变化。
在正常男性和女性志愿者口服索他洛尔前后进行22.5小时动态心电图监测,测量QT、R-R和TQ间期。此外,将其与一名接受单剂量索他洛尔的心脏病患者发生尖端扭转型室速之前时间匹配的数据集中观察到的情况进行比较。
在最大血药浓度时,160mg(n = 38)索他洛尔后QT、R-R和TQ间期分别增加71、101和125ms,320mg(n = 19)索他洛尔后分别增加194、235和135ms。索他洛尔治疗后22.5小时内,QT/TQ比值>1的搏动百分比降低了25%,TQ间期下限(第5百分位数)增加了22%-30%。相比之下,尖端扭转型室速发作前99%的搏动QT/TQ比值>1,索他洛尔治疗前后TQ间期中位数均低于正常下限98%置信区间。
在健康受试者的不同状态(夜间、β受体阻滞剂、QT延长)下,心电图恢复变化是可量化的。